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or Percutaneous Coronary Interventions
n Analysis From Two Large Multicenter
ercutaneous Coronary Intervention Databases
auro Moscucci, MD,* Kim A. Eagle, MD,* David Share, MD, MPH,† Dean Smith, PHD, MS,*
nthony C. De Franco, MD,‡ Michael O’Donnell, MD,§ Eva Kline-Rogers, RN, MS,*
andeep M. Jani, MPH,* David L. Brown, MD
nn Arbor, Detroit, and Flint, Michigan; and Stony Brook, New York
OBJECTIVES The purpose of this research was to determine the potential effect of public reporting on case
selection for percutaneous coronary intervention (PCI).
BACKGROUND Previous studies have suggested that public reporting of coronary artery bypass graft surgery
(CABG) mortality might result in case selection bias and in denial of care to or out migration
of high-risk patients. The potential effect of public reporting on case selection for PCI is
unknown.
METHODS We compared demographics, indications, and outcomes of 11,374 patients included in a
multicenter (eight hospitals) PCI database in Michigan where no public reporting is present,
with 69,048 patients in a statewide (34 hospitals) PCI database in New York, where public
reporting is present. The primary end point was in-hospital mortality.
RESULTS Patients in Michigan more frequently underwent PCI for acute myocardial infarction (14.4%
vs. 8.7%, p  0.0001) and cardiogenic shock (2.56% vs. 0.38%, p  0.0001) than those in
New York. The Michigan cohort also had a higher prevalence of congestive heart failure and
extracardiac vascular disease. The unadjusted in-hospital mortality rate was significantly lower
in New York than in Michigan (0.83% vs. 1.54%, p  0.0001; odds ratio [OR] 0.54, 95%
confidence interval [CI] 0.45 to 0.63). However, after adjustment for comorbidities, there was
no significant difference in mortality between the two groups (adjusted OR 1.05, 95% CI 0.84
to 1.31, p  0.70, c-statistic 0.88).
CONCLUSIONS There are significant differences in case mix between patients undergoing PCI in Michigan
and New York that result in marked differences in unadjusted mortality rates. A propensity
in New York toward not intervening on higher-risk patients because of fear of public
reporting of high mortality rates is a possible explanation for these differences. (J Am Coll
ublished by Elsevier Inc. doi:10.1016/j.jacc.2005.01.055Cardiol 2005;45:1759–65) © 2005 by the American College of Cardiology Foundation
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ahe past decade has been characterized by increased scru-
iny of outcomes of surgical and percutaneous cardiovascular
rocedures. Heightened interest in procedural outcomes has
ed to the development of regional, state, and national
atabases for outcome assessment and, in some cases, for
See page 1766
ublic reporting. In particular, the development and valida-
ion of risk-adjustment models for coronary artery bypass
raft surgery (CABG) mortality (1–5) has led to the
evelopment of report cards for cardiac surgery. More
ecently, risk-adjustment models for percutaneous coronary
ntervention (PCI) mortality have been developed and used
or the comparison and public reporting of operator- and
ospital-specific outcomes (6–9).
From the *University of Michigan Health System, Ann Arbor, Michigan; †Blue
ross Blue Shield Center for Health Care Quality, Detroit, Michigan; ‡McLaren
egional Medical Center, Flint, Michigan; §St. Joseph Mercy Hospital, Ann Arbor,
ichigan; and the State University of New York–Stony Brook School of Medicine,
tony Brook, New York. Supported by an unrestricted grant from Blue Cross Blue
hield of Michigan, Detroit, Michigan.v
Manuscript received September 10, 2004; revised manuscript received January 13,
005, accepted January 17, 2005.Previous studies have suggested that public reporting of
ABG outcomes might result in case selection bias and
enial of care to or out migration of high-risk patients to
ther states (10–12). However, the potential effect of public
eporting on case selection for PCI has not been investi-
ated. Therefore, we compared demographic data, indica-
ions, and in-hospital mortality from large multicenter PCI
atabases in Michigan, where public reporting is not man-
ated, and in New York, where public reporting of PCI data
s mandatory.
ETHODS
aseline demographic data, clinical data, and indications for
CI were prospectively collected from 11,374 consecutive
CIs in a consortium of 8 hospitals in Michigan from
alendar years 1998 to 1999, and 69,048 consecutive PCIs
rom all 34 hospitals performing PCI in New York from the
ame time period.
ichigan registry. The registry is part of the quality
ssessment and quality improvement program of hospitals
oluntarily participating in the consortium. The registry was
pproved by the University of Michigan Institutional Re-
iew Board and by local institutional review boards. The
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Public Reporting and Case Selection for PCI June 7, 2005:1759–65tructure of the consortium, the data collection process, and
he data quality assurance process have been described
lsewhere (2,13). In brief, data on all consecutive patients
ndergoing PCI in participating hospitals were prospec-
ively collected using standardized definitions and a stan-
ardized data form. The data collection forms were re-
iewed by the coordinating center for completeness and face
alidity. In addition, the structure of the database includes
iagnostic routines to further determine completeness and
alidity of the data submitted. All participating sites were
udited twice yearly. During the audit, 2% of cases were
elected at random for review, and, in addition, hospital
ecords of all patients who died in the hospital or who
nderwent CABG were audited. During the same audits,
ardiac catheterization logs were compared with the data-
ase logs to ensure enrollment of consecutive patients. A
rained nurse from one of the other participating centers
udited the coordinating center.
ew York registry. The study sample included 69,048
onsecutive patients undergoing PCI in all 34 New York
ospitals from January 1, 1998, to December 31, 1999.
rospectively defined data elements were contributed by
ach hospital to a central coordinating center for analysis.
ata elements included information on demographics, co-
orbidities, procedural details, complications, and in-
ospital outcomes. These data elements are required to be
ubmitted to the Department of Health on every PCI
erformed in New York State to make up the Coronary
ngioplasty Reporting System database.
efinitions. Intravenous glycoprotein IIb/IIIa inhibitors
ere considered to be administered when abciximab, epti-
batide, or tirofiban were given during or within 3 h after
CI. Periprocedural myocardial infarction (MI) was defined
n the New York registry as transmural MI (new Q waves
nd a rise in creatine kinase to at least 2.5 the upper limit
f normal occurring within 24 h of the PCI) or nontrans-
ural MI (determined according to individual hospital
uidelines for the diagnosis of nontransmural MI). In the
ichigan registry, periprocedural MI was defined as non–
-wave MI (any rise in creatine phosphokinase-MB frac-
ion above the individual institution’s normal within 24 h of
CI, without new Q waves on electrocardiogram) and
-wave MI (development of new Q waves that are 0.03 s in
idth and/or greater than or equal to one-third of the total
RS complex in contiguous leads and as evidenced by
ubsequent CPK-MB rise to 3  the baseline value just
efore intervention).
Abbreviations and Acronyms
CABG  coronary artery bypass graft surgery
CI  confidence interval
MI  myocardial infarction
OR  odds ratio
PCI  percutaneous coronary interventionHeparin therapy indicates treatment with intravenous meparin within 48 h before the PCI. Nitroglycerin treat-
ent indicates therapy with intravenous nitroglycerin
ithin 24 h of the procedure for ongoing ischemia or left
entricular failure. Diabetes mellitus is defined by treatment
ith oral hypoglycemic agents or insulin.
Creatinine values in the New York registry were collected
s a dichotomous variable (2.5 or 2.5), whereas in the
ichigan registry they were collected as continuous vari-
bles. For the purpose of this analysis, the definition of renal
nsufficiency was standardized as a serum creatinine 2.5
g/dl. Extracardiac vascular disease was defined as history
f stroke or peripheral vascular disease.
issing data. Left ventricular ejection fraction was miss-
ng in 27.8% of Michigan patients and 12.1% of New York
atients. Missing ejection fraction values were imputed (14)
sing a multivariate model that included age, gender,
istory of smoking, history of diabetes, history of PCI,
istory of congestive heart failure, renal failure with dialysis,
istory of extracardiac vascular disease, acute MI, cardiogenic
hock, preprocedure intra-aortic balloon pump, creatinine
2.5 mg/dl, and preprocedure intravenous use of nitroglyc-
rin or heparin. In the Michigan data set, creatinine values
ere missing in 8.4% of cases. Missing creatinine values
ere assumed to be 2.5 mg/dl.
CI. All procedural decisions, including device selection
nd adjunctive pharmacotherapy, were made at the discre-
ion of the individual physician performing the PCI. An-
iographic assessments were made at the individual hospital
nd generally were achieved by visual assessment. Cardiac
nzymes (creatine kinase and creatine kinase MB isoenzyme
r troponin) were obtained by protocol before and at 8 and
4 h after PCI in the New York registry and at the
iscretion of the operator in the Michigan registry.
nd points and statistical analysis. The primary end
oint of this analysis was in-hospital mortality. Univariate
ssociations among risk groups for nominal variables were
ompared using Pearson chi-square test. The two-tailed
tudent t test was used for continuous variables. A p 0.05
as considered significant.
Multivariate logistic regression models were fitted in order
o obtain adjusted estimates for the odds ratios (ORs) of
n-hospital mortality in the New York data set versus the
ichigan data set. Predicted mortality rates for each hospital
ere also calculated. SAS version 8.2 (SAS Institute, Cary,
orth Carolina) was utilized for all analyses. Model discrim-
nation was assessed using the c-statistic, and model cali-
ration was assessed using the Hosmer-Lemeshow statistic.
ESULTS
emographics. Baseline clinical characteristics are listed in
able 1. Overall, data from 80,422 consecutive procedures
ere analyzed. The average age was 63  11.9 years, and
2% of patients were women. Patients in Michigan had a
ignificantly higher incidence of renal insufficiency, diabetes
ellitus, chronic obstructive pulmonary disease, extracar-
d
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June 7, 2005:1759–65 Public Reporting and Case Selection for PCIiac vascular disease, congestive heart failure, and previous
CI (all p  0.001). Patients in the New York dataset were
lightly older (63.6  11.8 years vs. 62.0  12.0 years, p 
.0001) and had a higher frequency of hypertension.
ndications for PCI and in-hospital mortality rates. Pa-
ients undergoing PCI in Michigan were more likely to be
iven preprocedure intravenous heparin or preprocedure
ntravenous nitroglycerin (Table 1). Patients in Michigan
ore often underwent PCI in the setting of cardiogenic
hock, cardiac arrest, or acute MI.
The unadjusted in-hospital mortality rate was signifi-
antly higher in Michigan than in New York, (1.54% vs.
.83%; p  0.0001). Significant differences in mortality
ates were also observed in the subgroups of patients with
cute MI and cardiac arrest (Table 2).
ultivariate regression modeling. The unadjusted OR
or mortality of New York versus Michigan was 0.54
95% confidence interval [CI] 0.45 to 0.63; p  0.0001;
- statistic  0.55; Table 3). Only small changes in the OR
nd c-statistic were observed after adjustment for age and
ender alone. However, after adjustment for age, gender,
able 1. Baseline Demographic Data, Historical Data, Preproced
Variable
emographic variables
Age, mean (SD)
Male
Lean (BMI 25)
Overweight (25 BMI 30)
Obese (BMI 30)
Current smoking
istorical variables
Hypertension
Diabetes mellitus
Previous congestive heart failure
Congestive heart failure on admission
Extracardiac vascular disease
Renal failure with dialysis
Chronic obstructive pulmonary disease
Previous percutaneous coronary intervention
Previous heart surgery*
Laboratory values
Ejection fraction 50%
Ejection fraction 40%
Creatinine 2.5
reprocedure variables
Cardiac arrest
Pre-PCI intravenous nitroglycerin
Pre-PCI intravenous heparin
Both pre-PCI intravenous nitroglycerin and heparin in
patients without acute myocardial infarction
Pre-PCI intra-aortic balloon pump
ndications for PCI
Myocardial infarction within 14 days
Acute myocardial infarction (24 h)
Cardiogenic shock
Cardiogenic shock in patient with acute myocardial infarction
In the Michigan registry, prior heart surgery is defined as prior coronary artery bypa
BMI  body mass index; PCI  percutaneous coronary intervention.ther clinical risk factors, and hospital procedure volume, the survival advantage in the New York dataset was no
onger significant (adjusted OR for mortality 1.05, 95% CI
.84 to 1.31; p  0.70; c-statistic  0.88; Hosmer-
emeshow chi-square 9.6, p  0.29) (Tables 3 and 4). To
etermine the potential effect of the imputed missing
jection fraction values on the result, a model excluding
jection fraction as an explanatory variable was developed.
emoval of ejection fraction from the model did not change
he result of the analysis (adjusted OR for mortality 1.09,
5% CI 0.87 to 1.36; p  0.45; c-statistic  0.88;
osmer-Lemeshow chi-square 11.8, p  0.15).
Predicted mortality rates based on case mix in the 8
ichigan hospitals and in the 34 New York hospitals are
hown in Figure 1. The median predicted mortality rate in
he Michigan hospitals was 1.63% when compared with a
edian predicted mortality rate of 0.76% in the group of
ew York hospitals (p  0.0002). In addition, in the group
f New York hospitals, there was only one hospital that had
predicted mortality rate equal to the median of the
ichigan hospitals. Substantial differences were also ob-
erved in the frequency of PCI for cardiogenic shock among
ariables, and Indications for PCI
York (%) Michigan (%) All Patients (%)
p Value69,048) (n  11,374) (n  80,422)
(11.8) 62.0 (12.0) 63.4 (11.9) 0.0001
7.8 67.9 67.9 0.81
5.1 22.0 24.6 0.0001
2.6 39.9 42.2 0.0001
2.5 38.2 33.3 0.0001
4.1 28.1 24.7 0.0001
8.0 62.3 67.2 0.0001
4.2 26.4 24.5 0.0001
5.0 9.4 5.6 0.0001
5.8 6.5 5.9 0.003
9.2 15.1 10.0 0.0001
1.0 1.4 1.0 0.0005
5.0 10.5 5.8 0.0001
8.2 31.2 28.6 0.0001
6.4 16.9 16.4 0.13
2.1 29.5 31.8 0.0001
2.1 10.8 11.9 0.0001
1.5 1.9 1.6 0.005
0.18 1.57 0.37 0.0001
0.4 32.4 22.2 0.0001
9.8 46.4 40.7 0.0001
5.5 39.6 36.1 0.0001
1.13 0.84 1.09 0.005
6.6 33.2 27.5 0.0001
8.71 14.40 9.51 0.0001
0.38 2.56 0.69 0.0001
3.5% 14.3% 5.8% 0.0001
fting; in the New York registry, prior heart surgery includes any open heart surgery.ure V
New
(n 
63.6
6
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2he two groups (Fig. 2).
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Public Reporting and Case Selection for PCI June 7, 2005:1759–65ISCUSSION
n this analysis of contemporaneous PCI, we evaluated
ifferences in case mix and in-hospital mortality rates
etween two large, quality-controlled regional PCI regis-
ries. One registry operates in Michigan, a state without
ublic reporting of clinical outcomes. The other registry was
erived in New York, a state with mandatory public
eporting of clinical outcomes after CABG and PCI. We
ound significant differences in comorbidities and indica-
ions for PCI between the two registries. Overall, the
atient population in the Michigan registry had a signifi-
antly higher frequency of comorbidities. The majority of
hese comorbidities have been identified in previous studies
s independent risk factors for PCI mortality. In addition, a
ignificantly higher frequency of PCI in the setting of
ardiogenic shock, acute MI, and cardiac arrest was ob-
erved in the Michigan registry compared with the New
ork registry. Each one of these indications for PCI has also
een previously identified as an independent predictor of
n-hospital death and has been included in validated risk-
djustment models for PCI mortality (6,7). As a result of
he higher incidence of comorbidities and high-risk indica-
ions for PCI, we found a strikingly higher (almost two-
old) unadjusted in-hospital mortality rate in the Michigan
egistry compared to the New York registry.
Table 2. In-Hospital Outcomes
Variable
New York
(n  69,04
In-hospital outcomes
Death 0.83
Myocardial infarction 1.95
Stroke/transient ischemic attack 0.29
Emergency coronary artery
bypass grafting
0.38
Major adverse cardiac events* 3.16
Revascularization (same vessel) 0.58
Vascular complications 0.54
Mortality rates in patient subgroups
Cardiogenic shock 37.9
Acute myocardial infarction,
no cardiogenic shock
2.97
Any acute myocardial infarction† 4.23
Cardiac arrest 32.8
*Includes death, myocardial infarction, stroke/transient isch
higher mortality rate in the Michigan group with any acute
cardiogenic shock in this patient group (Table 1).
able 3. Unadjusted and Adjusted Odds Ratios for Death in New
Models Odds Ratio
nadjusted 0.54
ge- and gender-adjusted 0.49
Plus historical and other risk variables* 1.07
Plus historical, other risk variables, and hospital
volume (400 procedures/yr)*
1.05
Adjusted for New York vs. Michigan, gender, age, history of extracardiac vascular
bstructive pulmonary disease, previous percutaneous coronary intervention (PCI), co
yocardial infarction, creatinine 2.5 mg/dl, left ventricular ejection fraction 40%, use of
CI.The higher in-hospital mortality rate observed in Mich-
gan was explained by the differences in comorbidities and
ndications for PCI. As shown by logistic regression mod-
ling and analysis of the c-statistic, the variable New York
ersus Michigan alone had little discriminatory power in
xplaining differences in mortality rates (c-statistic  0.55).
ome additional discriminatory power was added by age and
ender. However, the inclusion of comorbidities and indi-
ations for PCI significantly improved model discrimination
c-statistic  0.88). In the final model, the variable New
ork versus Michigan was no longer an independent pre-
ictor of in-hospital mortality.
The most obvious differences between the New York and
ichigan registries were the differences in case mix and the
resence or absence of public reporting. Although we do not
ave any direct proof, a case selection bias driven by the fear
f public reporting of higher mortality rates in New York
as one possible explanation for the observed differences in
ase mix and mortality rates.
linical and health policy implications. The publication
n 1987 by the Health Care Financial Administration of
ortality statistics for CABG has led to the development of
egional and state registries for outcome assessment and
isk-adjustment. Over the past decade, New York has
ssumed an important leadership role in outcome assess-
Michigan (%) All Patients (%)
p Value(n  11,374) (n  80,422)
1.54 0.93 0.0001
2.04 1.96 0.51
0.51 0.32 0.0001
0.85 0.44 0.0001
4.45 3.34 0.0001
0.70 0.60 0.11
1.99 0.75 0.0001
31.3 34.4 0.10
2.28 2.83 0.16
6.72 4.76 0.0001
20.1 25.2 0.01
ttack, and emergency coronary artery bypass grafting; †the
rdial infarction is due to a significantly higher frequency of
rk Versus Michigan
95% Confidence Interval p Value c-Statistic
0.45–0.63 0.0001 0.55
0.42–0.59 0.0001 0.71
0.86–1.33 0.56 0.88
0.84–1.31 0.70 0.88
, diabetes mellitus, renal failure requiring dialysis, congestive heart failure, chronic
ve heart failure on admission, PCI in the presence of a myocardial infarction, acute(%)
8)
emic aYo
disease
ngestian intra-aortic balloon pump before PCI, and use of cardiopulmonary support before
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June 7, 2005:1759–65 Public Reporting and Case Selection for PCIent for patients undergoing CABG and PCI. Data
ollection for this effort started in the late 1980s and has
ontinued uninterrupted. In 1991, under the Freedom of
nformation Act, New York was ordered by the Supreme
ourt to release mortality statistics for CABG to the
ewspaper Newsday (1). Those statistics were published in
he December 18, 1991, issue of Newsday, and, since then,
ublic reporting of hospital- and operator-specific outcomes
Table 4. Multivariate Model for In-Hospital D
Model Variable
New York (reference Michigan)
Female gender
Age 60–69 yrs
Age 70–79 yrs
Age 80 yrs
Low-volume hospital (400 per yr)
Congestive heart failure upon admission
History of chronic obstructive pulmonary disease
History of percutaneous coronary intervention
History of extracardiac vascular disease
History of renal failure with dialysis
Diabetes mellitus
Acute myocardial infarction (24 h)
Myocardial infarction (within 7 days)
Cardiogenic shock
Cardiac arrest
Preprocedure cardiopulmonary support
Preprocedure intraaortic balloon pump
Creatinine 2.5 mg/dl
Ejection fraction 40%
c-statistic
igure 1. Predicted mortality rates by hospital. On the right, the black ba
he left, the white bars represent predicted mortality rates for the eight Michig
f medians for NY and MI).as become part of practicing medicine in New York. Over
he past decade, there has been a progressive decline in
ABG mortality in New York (15,16). More recently, a
ecline in PCI mortality has also been observed. The debate
ver the cause of these declines is ongoing. Advocates of
ublic reporting support the hypothesis that public exposure
o outcome data leads to internal quality improvement
fforts aimed at reducing the mortality rates from revascu-
dds Ratio
95% Confidence
Interval p Value
1.05 0.84–1.31 0.70
1.45 1.23–1.71 0.0001
1.60 1.23–2.07 0.0005
3.55 2.80–4.49 0.0001
6.59 5.06–8.58 0.0001
1.77 1.16–2.70 0.008
2.52 2.09–3.05 0.0001
1.42 1.11–1.83 0.006
0.76 0.62–0.94 0.01
2.10 1.75–2.53 0.0001
2.21 1.35–3.61 0.002
1.49 1.26–1.78 0.0001
3.32 2.67–4.14 0.0001
2.00 1.61–2.48 0.0001
8.72 6.61–11.50 0.0001
4.58 3.14–6.69 0.0001
7.01 2.14–22.96 0.001
2.60 1.97–3.42 0.0001
2.30 1.57–3.38 0.0001
1.61 1.35–1.94 0.0001
0.88
resent predicted mortality rates for the 34 New York (NY) hospitals. Oneath
Ors rep
an (MI) hospitals (p  0.0002 for Wilcoxon rank sum test for differences
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Public Reporting and Case Selection for PCI June 7, 2005:1759–65arization procedures (15,16). On the other hand, some
tudies have shown that mandatory reporting of outcome
ata can lead to gaming of health care claims by the addition
f comorbidities not previously identified as clinically im-
ortant, to denial of care to high-risk patients, and to out
igration of high-risk patients to other states where public
eporting does not occur (10–12). In addition, a recent
nalysis of secular trends in CABG mortality in the North-
ast showed declining mortality rates in states where public
eporting does not occur similar to the ones observed in
ew York over the same time period. These findings call
nto question the extent to which public reporting was
esponsible for sustaining improvement in surgical mortality
ver time (17,18). Others have suggested that the decline in
ABG mortality rates in New York State may have been
aused by changes in the way surgical centers collected data
ver the time period (3). It seems likely that the reduction
n CABG mortality is attributable to a combination of all
hese factors.
Public report cards are often developed from adequate
ortality data but without adequate risk-adjustment or by
sing claims data that lack sufficient detail to perform a
horough risk-adjustment (19,20). Our analysis argues that
uality-controlled clinical data with appropriate risk-
djustment for demographics, comorbidities, and treatment
ariables is necessary for meaningful outcomes information.
t also supports the hypothesis that appropriate risk-
djustment can account for significantly different mortality
igure 2. Frequency of percutaneous coronary intervention (PCI) for card
CI for cardiogenic shock in the 34 New York hospitals. On the left, the wh
ospitals.ates (a two-fold difference in this study). YIt is likely that public reporting of outcomes information
ill become more commonplace in the health care system.
lthough public reporting has not yet been linked to
ubstantial shifts in hospital volumes due to doctor or
ospital “shopping,” as it becomes more popular, patients,
ayers, insurers, and other interested parties will begin to
ay more attention to the information provided (21–24).
he derivation of accurate outcomes information will as-
ume great importance to health care institutions and
roviders as report cards gain increasing acceptance and
rominence. Although making accurate outcomes informa-
ion accessible has the potential to improve healthcare, our
tudy suggests that public reporting of outcome data might
lso have an unintended effect on case selection, leading to
tendency toward not intervening on higher-risk patients.
ore studies will be needed to determine the full effect of
ublic reporting on quality and access to care.
tudy limitations. There are several important limita-
ions of the current study. First, this analysis compared
ata from two registries collected in two different states.
n assumption was made that the patient populations
cross the two states were comparable and that the case
ix differences observed in the two registries were due to
election bias rather than to true differences in comor-
idities. This statement is indirectly supported by statis-
ical data from the American Heart Association that
hows that the age-adjusted coronary heart disease death
ates per 100,000 are 210 in Michigan and 240.4 in New
ic shock by hospital. On the right, the black bars represent frequency of
ars represent frequency of PCI for cardiogenic shock in the eight Michiganiogenork. Thus, it is unlikely that fewer patients with MI or
c
p
M
d
t
a
m
t
a
t
r
t
Y
r
fi
t
M
a
a
g
t
t
s
w
m
p
o
u
o
C
b
N
a
i
t
b
d
R
T
A
R
1
1
1
1
1
1
1
1
1
1
2
2
2
2
2
2
2
1765JACC Vol. 45, No. 11, 2005 Moscucci et al.
June 7, 2005:1759–65 Public Reporting and Case Selection for PCIardiogenic shock underwent PCI in New York because the
opulation suffered fewer MIs than the population in
ichigan. In addition, we were unable to assess whether a
ifferent approach existed between the two states relating to
he possible futility of procedures performed. In a previous
nalysis, we have shown that mortality rates in patients with
ultiple comorbidities are high regardless of the results of
he procedure performed, and that these high mortality rates
re due to the natural history of the disease rather than to
he procedure itself (6). Whether PCI in these very high-
isk patients is futile, and whether the differences between
he two registries were due to a futility assessment in New
ork remains to be determined. However, numerous prior
andomized trials and registry studies have shown a bene-
cial effect of PCI in patients with acute MI (25).Therefore,
he finding that the frequency of PCI in patients with acute
I in New York was roughly half the frequency of PCI for
cute MI in Michigan is a concern. Adding to this concern
re the results of a recent survey of interventional cardiolo-
ists practicing in New York State in 1998 to 2000 (26). In
hat survey, the majority of respondents (79%) agreed that
he publication of mortality statistics influenced their deci-
ion to intervene on critically ill patients, such as patient
ith cardiogenic shock, and 83% agreed that patients who
ight benefit from angioplasty may not receive the
rocedure as a result of public reporting. Thus, the
bserved differences in our study may represent an
nintended and adverse consequence of public reporting
f outcomes data.
onclusions. There are important variations in case mix
etween patients undergoing PCI in Michigan compared to
ew York. These differences explain the significant discrep-
ncies in unadjusted mortality rates and suggest a propensity
n New York toward not intervening on higher-risk pa-
ients. A fear of public reporting resulting in case selection
ias in New York is one possible explanation for these
ifferences.
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